Differential chromosome allelic imbalance in the progression of human prostate cancer

Journal of Urology

Volumn 156, Issue 6, 1996, Pages 2079-2083

  Latil, Alain ^b   Fournier, Georges ^b   Cussenot, Olivier ^b   Lidereau, Rosette ^a  

^a CENTRE RENÉ HUGUENIN   (France)

^b NONE

Author keywords

allelic influence; loss of heterozygosity; prostate cancer; tumor suppressor gene

Indexed keywords

ALLELE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

EID: 0029911382     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65439-9     Document Type: Article

References (41)

1. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smith, A. M. and Bos, J. L.: Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525, 1988.
2. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I. and Isaacs, W. B.: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A., 87: 8751, 1990.
3. Bergerheim, U., Kumini, K., Collins, P. V. and Ekman, P.: Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chrom. Cancer, 3: 215, 1991.
4. Bova, G. S., Carter, B. S., Bussemakers, M. J., Emi, M., Fujiwara, Y., Kiprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., Walsh, P. C. and Isaacs, W. B.: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869, 1993.
5. Latil, A., Baron, J-C., Cussenot, O., Fournier, G., Soussi, T., Boccon-Gibod, L., Leduc, A., Rouëssé, J. and Lidereau, R.: Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome 18q. Genes Chrom. Cancer, 11: 119, 1994.
6. Gao, X., Zacharek, A., Salkowski, A., Grignon, D. J., Sakr, W., Porter, A. T. and Honn, K. V.: Loss of heterozygosity of BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res., 55: 1002, 1995.
7. Zenklusen, J. C., Thompson, J. C., Troncoso, P., Kagan, J. and Conti, C. J.: Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res., 54: 6370, 1994.
8. Weber, J. L. and May, P. E.: Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet., 44: 388, 1989.
9. Mellinger, G. T., Gleason, D. and Bailar, J.: The histology and prognosis of prostatic cancer. J. Urol., 97: 331, 1967 III.
10. Schroder, F. H., Hermanek, P., Denis, L., Fair, W. R., Gospodarowicz, M. K. and Pavone-Macaluso, M.: The TNM classification of prostate cancer. Prostate, Suppl 4: 129, 1992.
11. Bostwick, D. G., Myers, R. P. and Oesterling, J. E.: Staging in prostate cancer. Semin. Surg. Oncol., 10: 60, 1994.
12. Tomfohrde, J., Wood, S., Schertzer, M., Wagner, M. J., Wells, D. E., Parrish, J., Sadler, L. A., Blanton, S. H., Daiger, S. P., Wang, Z., Wilkie, P. J. and Weber, J. L.: Human chromosome 8 linkage map based on short tandem repeat polymorphisms: effect of genotyping errors. Genomics, 14: 144, 1992.
13. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G. and Lathrop, M. A.: Second-generation linkage map of the human genome. Nature, 359: 794, 1992.
14. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. and Weissenbach, J.: The 1993-94 Genethon human genetic linkage map. Nature Genetics, 7: 246, 1994.
15. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Stano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Briston, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A. and Skolnick, M. H.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266: 66, 1994.
16. McGrogan, D., Levy, A., Bostwick, D., Wagner, M., Wells, D. and Bookstein, R.: Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chrom. Cancer, 10: 151, 1994.
17. Cairns, P., Tokino, K., Eby, Y. and Sidransky, D.: Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54: 1422, 1994.
18. Hudson, T. J., Engelstein, M., Lee, M. K., Ho, E. C., Rubenfield, M. J., Adams, C. P., Housman, D. E. and Dracopoli, N. C.: Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics, 13: 622, 1992.
19. Watanabe, M., Imai, H., Shiraishi, T., Shimazaki, J., Kotate, T. and Yatani, R.: Microsatellite instability in human prostate cancer. Br. J. Cancer, 72: 562, 1995.
20. Cher, M. L., MacGrogan, D., Bookstein, R., Brown, J. A., Jenkins, R. B. and Jensen, R. H.: Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chrom. Cancer, 11: 153, 1994.
21. Visakorpi, T., Kallioniemi, A. H., Syvänen, A-C., Hyytinen, E. R., Karhu, R., Tammella, T., Isola, J. J. and Kallioniemi, O-P.: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342, 1995.
22. Phillips, S. M. A., Barton, C. M., Lee, S. J., Morton, D. G., Wallace, D. M. A., Lemoine, N. R. and Neoptolemos, J. P.: Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br. J. Cancer, 70: 1252, 1994.
23. Fujiwara, Y., Ohata, H., Emi, M., Okui, K., Koyama, K., Tsuchiya, E., Nakajima, T., Monden, M., Mori, T., Kurimasa, A. and Nakamura, Y.: A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-Kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chrom. Cancer, 10: 7, 1994.
24. Gao, X., Honn, K. V., Grignon, D., Sakr, W. and Chen, Y. Q.: Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res., 53: 2723, 1993.
25. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G. M., Lynch, H., Feunteun, J., Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Ormiston, W., McManus, R., Pye, C., Lewis, C. M., Cannon-Albright, L. A., Peto, J., Ponder, B. A. J., Skolnick, M. H., Easton, D. F., Goldgar, D. E. and Stratton, M. R.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-q13. Science, 265: 2088, 1994.
26. Arason, A., Barkardòttir, R. B. and Egilsson, V.: Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Iceland families, and possible relationship to prostatic cancer. Am. J. Hum. Genet., 52: 711, 1993.
27. Kerangueven, F., Allione, F., Noguchi, T., Sobol, H., Jacquemier, J. and Birnbaum, D.: Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chrom. Cancer, 13: 291, 1995.
28. Sarkar, F. H., Sakr, W. A., Li, Y. W., Macoska, J., Ball, D. E. and Crissman, J. D.: Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate, 21: 145, 1992.
29. Brewster, S. F., Browne, S. and Brown, K.: Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. J. Urol., 151: 1073, 1994.
30. McPherson, J. D., Morton, R. A., Ewing, E. M., Wasmuth, J. J., Overhauser, J., Nagafuchi, A., Tsukita, S. and Isaacs, W. B.: Assignment of the human α catenin gene (CTNNA1) to chromosome 5q21-q22. Genomics, 19: 188, 1994.
31. Takahashi, S., Shan, A. L., Ritland, S. R., Delacey, K. A., Bostwick, D. G., Lieber, M. M., Thibodeau, S. N. and Jenkins, R. B.: Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res., 55: 4114, 1995.
32. Suzuki, H., Emi, N., Komiya, A., Fujiwara, Y., Yatani, R., Nakamura, Y. and Shimazaki, J.: Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chrom. Cancer, 13: 168, 1995.
33. Trapman, J., Sleddens, H. F. B. M., van der Weiden, M. M., Dinjens, W. N. M., Konig, J. J. and Schroder, F. H.: Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res., 54: 6061, 1994.
34. Natt, E., Magenis, R. E., Zimmer, J., Mansouri, A. and Scherer, G.: Regional assignment of the human loci for uvomorulin and chymotrypsinogen B with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet. Cell Genet., 50: 145, 1989.
35. Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. J., Brooks, J. D. and Ewing, C. M.: Molecular genetics and chromosomal alterations in prostate cancer. Cancer, suppl 7: 2004, 1995.
36. Umbas, R., Isaacs, W. B., Bringier, P. P., Schaafsma, H. E., Karthaus, H. F. M., Oosterhof, G. O. N., Debruyne, F. M. J. and Schalken, J. A.: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929, 1994.
37. Cher, M. L., Ito, T., Weidner, N., Carroll, P. R. and Jensen, R. H.: Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J. Urol., 153: 249, 1995.
38. Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T. and Hirohashi, S.: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A., 87: 6791, 1990.
39. Cleton-Jansen, A-M., Moerland, E. W., Kuipers-Dijkshoorn, N. J. K., Callen, D. F., Sutherland, G. R., Hansen, B., Devilee, P. and Cornelisse, C. J.: At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Gene Chrom. Cancer, 9: 101, 1994.
40. Tsuda, H., Callen, D. F., Fukutomi, T., Nakamura, Y. and Hirohashi, S.: Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res., 54: 513, 1994.
41. Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Atkin, N. B. and Prochownik, E. V.: Mutation of the MXI1 gene in prostate cancer. Nature Genetics, 9: 249, 1995.